The Betapharm Acquisition: DRL`s Inorganic Growth Strategy in Europe (French)
Details
Case Code:
OFBSTR249
Case Length:
19
Period:
Pub Date:
2007
Teaching Note:
YES
Price (Rs):
500
Organization:
Dr. Reddyâs Laboratories Ltd.
Industry:
Pharmaceuticals & Biotech
Country:
Germany; India
Themes:
M&A,Operations Strategy, Market Entry
Abstract
Learning Objectives
The case is structured to achieve the following Learning Objectives:
Keywords
betapharm Arzneimittel GmbH, Dr. Reddy's Laboratories Ltd., Mergers and Acquisitions, Strategic Management, German Pharmaceutical Generic Market, Value Creation, Drug Discovery and Development, Low-Cost Manufacturing Outsourcing, Corporate Social Responsibility, Ranbaxy Laboratories Limited, Political and Regulatory Environment, Economic Optimisation of Pharmaceutical Care Act, International Market Expansion, Globalization, Post-merger Integration Plan
Related Case Studies
| Case Title | Details | Price | Add to Cart |
|---|---|---|---|
|
Case Title China`s Midea Group`s Intelligent Manufacturing Strategy for Creating a New Human-Machine EcosystemCase Code: OPER158 |
Details | 500 | Add to Cart |
|
Case Title Styched: Re-Thinking Fast Fashion through AICase Code: ITSY120 |
Details | 400 | Add to Cart |
|
Case Title Can Wal-Mart Make It In India?Case Code: CLBS153 |
Details | 200 | Add to Cart |
|
Case Title McDonaldâs Franchise in India: Spiraling toward a DeadlockCase Code: CLBS146 |
Details | 200 | Add to Cart |
|
Case Title Uberâs Exit from China: A Raw Deal?Case Code: BSTR504 |
Details | 500 | Add to Cart |